A leader in pre-clinical models of neurodegeneration, Peter has also been CSO of a successful public biotech company. He is also Emeritus Professor of Pharmacology at King’s College London.
Professor Peter Jenner joins as CSO2015-05-072015-05-07https://chronosthera.wpengine.com/wp-content/uploads/2017/09/vector-smart-object025x.pngChronos Therapeuticshttps://chronosthera.wpengine.com/wp-content/uploads/2017/09/vector-smart-object025x.png200px200px